Lim T O, Lim Y N, Wong H S, Ahmad G, Singam T S, Morad Z, Suleiman A B, Rozina G, Ong L M, Hooi L S, Shaariah W, Tan C C, Loo C S
Department of Nephrology, Hospital Kuala Lumpur.
Med J Malaysia. 1999 Dec;54(4):459-70.
We describe the outcomes on haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) provided by the Ministry of Health (MOH). The assessment was based on data from the Malaysian Dialysis Registry on 2480 HD and 732 CAPD patients who commenced dialysis between 1980 and 1996. Young patients (age < 40) have remarkable long term survival (life expectancies of 16 years on HD, 18 years on CAPD). Adjusting for background mortality, relative survival of older patients was as good as younger ones. Diabetics did poorly. 52% of HD and 26% of CAPD patients were employed in 1996. 71% of HD patients scored 10(normal) on QL index (a measure of quality of life) while 60% of CAPD patients have similar score. Differences in rehabilitation and QL index scores by age, gender and diabetes were also observed. Outcomes of dialysis in the MOH programme are reassuring.
我们描述了卫生部提供的血液透析（HD）和持续性非卧床腹膜透析（CAPD）的治疗结果。评估基于马来西亚透析登记处的数据，这些数据来自1980年至1996年间开始透析的2480例血液透析患者和732例腹膜透析患者。年轻患者（年龄<40岁）具有显著的长期生存率（血液透析患者的预期寿命为16年，腹膜透析患者为18年）。校正背景死亡率后，老年患者的相对生存率与年轻患者相当。糖尿病患者的情况较差。1996年，52%的血液透析患者和26%的腹膜透析患者受雇工作。71%的血液透析患者在QL指数（一种生活质量衡量指标）上得分为10（正常），而60%的腹膜透析患者得分相似。在康复情况以及QL指数得分方面，还观察到了年龄、性别和糖尿病之间的差异。卫生部项目中的透析治疗结果令人安心。
